Short Interest in Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Rises By 285.9%

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) was the recipient of a significant growth in short interest during the month of June. As of June 30th, there was short interest totaling 29,843 shares, a growth of 285.9% from the June 15th total of 7,733 shares. Based on an average trading volume of 9,737 shares, the short-interest ratio is currently 3.1 days. Approximately 3.3% of the company’s shares are short sold.

Institutional Investors Weigh In On Virtus LifeSci Biotech Products ETF

Institutional investors and hedge funds have recently modified their holdings of the company. Flow Traders U.S. LLC purchased a new position in Virtus LifeSci Biotech Products ETF during the 2nd quarter valued at about $431,000. Comprehensive Financial Planning Inc. PA purchased a new stake in shares of Virtus LifeSci Biotech Products ETF during the 4th quarter worth approximately $557,000. Finally, Prime Capital Investment Advisors LLC purchased a new stake in Virtus LifeSci Biotech Products ETF in the fourth quarter valued at $1,896,000.

Virtus LifeSci Biotech Products ETF Trading Down 0.5%

Virtus LifeSci Biotech Products ETF stock traded down $0.51 during mid-day trading on Tuesday, hitting $97.59. The company’s stock had a trading volume of 7,023 shares, compared to its average volume of 8,094. The stock’s fifty day moving average is $90.25 and its two-hundred day moving average is $85.40. Virtus LifeSci Biotech Products ETF has a 1 year low of $60.91 and a 1 year high of $105.21.

About Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.